By Reuters Staff
1 Min Read
STOCKHOLM (Reuters) - Buyout group EQT on Thursday raised its cash offer for contract pharmaceutical maker Recipharm, valuing the Swedish company at 24.9 billion Swedish crowns ($2.97 billion).
EQT raised its bid to 232 crowns per share from the 220 crowns it had offered in December.
“We consider this revised offer to be highly compelling for Recipharm’s shareholders,” EQT partner Erika Henriksson said in a statement.
EQT added that the bid would not be increased further.
Recipharm’s board of directors said in a separate statement they unanimously recommended shareholders and owners of convertible bonds to accept the bid.
Walgreens Boots Alliance said on Tuesday it named Roz Brewer, the outgoing chief operating officer of Starbucks, as the company's chief executive officer.
SoftBank Corp, Japan's third-largest telco, said on Tuesday Chief Technology Officer Junichi Miyakawa would become its chief executive officer, effective April 1.
2 Min Read
FILE PHOTO: SoftBank Corp Representative Director and CTO Junichi Miyakawa speaks during their joint news conference in Tokyo, Japan October 4, 2018. REUTERS/Issei Kato
TOKYO (Reuters) - SoftBank Corp, Japan’s third-largest telco, said on Tuesday Chief Technology Officer Junichi Miyakawa would become its chief executive officer, effective April 1.
The change at the top of one of SoftBank Group Corp’s largest assets comes after two years of deliberation, with the telco emphasising the need to “pass on the strengths of its current management system to future generations.”
The rotation is likely to lead to speculation over SoftBank Group CEO Masayoshi Son’s own succession plans. The 63-year-old billionaire abandoned a previous plan to hand over the reins and went on to launch the $100 billion Vision Fund.